A putative cis-acting polymorphism in the NOS1 gene is associated with schizophrenia and NOS1 immunoreactivity in the postmortem brain

Schizophrenia Research

Volumn 121, Issue 1-3, 2010, Pages 172-178

  Cui, Huxing ^a   Nishiguchi, Naoki ^b   Yanagi, Masaya ^a   Fukutake, Masaaki ^a   Mouri, Kentaro ^a   Kitamura, Noboru ^c   Hashimoto, Takeshi ^a   Shirakawa, Osamu ^b   Hishimoto, Akitoyo ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

Author keywords

Age of onset; Cis acting polymorphism.; Nitric oxide synthase; NOS1; Postmortem brain; Schizophrenia

Indexed keywords

NEURONAL NITRIC OXIDE SYNTHASE; NOS1 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; AUTOPSY; BRAIN TISSUE; CIS ISOMER; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; JAPANESE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHENOTYPE; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; SCHIZOPHRENIA; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; BRAIN; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; POSTMORTEM CHANGE; PROCEDURES;

ADULT; AGED; BRAIN; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE I; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMORTEM CHANGES; SCHIZOPHRENIA;

EID: 77955054147     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.05.003     Document Type: Article

References (41)

1. Akbarian S., Vinuela A., Kim J.J., Potkin S.G., Bunney W.E., Jones E.G. Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch. Gen. Psychiatry 1993, 50:178-187.
2. Akbarian S., Bunney W.E., Potkin S.G., Wigal S.B., Hagman J.O., Sandman C.A., et al. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch. Gen. Psychiatry 1993, 50:169-177.
3. Arinami T., Ohtsuki T., Ishiguro H., Ujike H., Tanaka Y., Morita Y., et al. Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p. Am. J. Hum. Genet. 2005, 77:937-944.
4. Baba H., Suzuki T., Arai H., Emson P.C. Expression of nNOS and soluble guanylate cyclase in schizophrenic brain. NeuroReport 2004, 15:677-680.
5. Bailer U., Leisch F., Meszaros K., Lenzinger E., Willinger U., Strobl R., et al. Genome scan for susceptibility loci for schizophrenia. Neuropsychobiology 2000, 42:175-182.
6. Bailer U., Leisch F., Meszaros K., Lenzinger E., Willinger U., Strobl R., et al. Genome scan for susceptibility loci for schizophrenia and bipolar disorder. Biol. Psychiatry 2002, 52:40-52.
7. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
8. Bernstein H.G., Bogerts B., Keilhoff G. The many faces of nitric oxide in schizophrenia. A review. Schizophr. Res. 2005, 78:69-86.
9. Bernstein H.G., Stanarius A., Baumann B., Henning H., Krell D., Danos P., et al. Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 1998, 83:867-875.
10. Black M.D., Selk D.E., Hitchcock J.M., Wettstein J.G., Sorensen S.M. On the effect of neonatal nitric oxide synthase inhibition in rats: a potential neurodevelopmental model of schizophrenia. Neuropharmacology 1999, 38:1299-1306.
11. Brenman J.E., Bredt D.S. Synaptic signaling by nitric oxide. Curr. Opin. Neurobiol. 1997, 7:374-378.
12. Bros M., Boissel J.P., Godtel-Armbrust U., Forstermann U. Transcription of human neuronal nitric oxide synthase mRNAs derived from different first exons is partly controlled by exon 1-specific promoter sequences. Genomics 2006, 87:463-473.
13. Cardno A.G., Gottesman I.I. Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am. J. Med. Genet. 2000, 97:12-17.
14. Contestabile A. Roles of NMDA receptor activity and nitric oxide production in brain development. Brain Res. Brain Res. Rev. 2000, 32:476-509.
15. DeLisi L.E., Shaw S.H., Crow T.J., Shields G., Smith A.B., Larach V.W., et al. A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. Am. J. Psychiatry 2002, 159:803-812.
16. Downen M., Zhao M.L., Lee P., Weidenheim K.M., Dickson D.W., Lee S.C. Neuronal nitric oxide synthase expression in developing and adult human CNS. J. Neuropathol. Exp. Neurol. 1999, 58:12-21.
17. Dupont W.D., Plummer W.D. Power and sample size calculations for studies involving linear regression. Control. Clin. Trials 1998, 19:589-601.
18. Fallin M.D., Lasseter V.K., Avramopoulos D., Nicodemus K.K., Wolyniec P.S., McGrath J.A., et al. Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am. J. Hum. Genet. 2005, 77:918-936.
19. Gibbs S.M. Regulation of neuronal proliferation and differentiation by nitric oxide. Mol. Neurobiol. 2003, 27:107-120.
20. Hara H., Waeber C., Huang P.L., Fujii M., Fishman M.C., Moskowitz M.A. Brain distribution of nitric oxide synthase in neuronal or endothelial nitric oxide synthase mutant mice using [3H]L-NG-nitro-arginine autoradiography. Neuroscience 1996, 75:881-890.
21. Herken H., Uz E., Ozyurt H., Akyol O. Red blood cell nitric oxide levels in patients with schizophrenia. Schizophr. Res. 2001, 52:289-290.
22. Ishihara T., Orikasa C., Araki T., Sakuma Y. Sex difference in the expression and regulation of nitric oxide synthase gene in the rat preoptic area. Neurosci. Res. 2002, 43:147-154.
23. Johnston N.L., Cervenak J., Shore A.D., Torrey E.F., Yolken R.H. Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR. Stanley Neuropathology Consortium. J. Neurosci. Methods 1997, 77:83-92.
24. Karolewicz B., Szebeni K., Stockmeier C.A., Konick L., Overholser J.C., Jurjus G., et al. Low nNOS protein in the locus coeruleus in major depression. J. Neurochem. 2004, 91:1057-1066.
25. Karson C.N., Griffin W.S., Mrak R.E., Husain M., Dawson T.M., Snyder S.H., et al. Nitric oxide synthase (NOS) in schizophrenia: increases in cerebellar vermis. Mol. Chem. Neuropathol. 1996, 27:275-284.
26. Leimert M., Blottner D. Neuronal nitric oxide synthase (bNOS) messenger RNA and protein expression in developing rat brainstem nuclei. Neurosci. Lett. 2003, 342:57-60.
27. Lin X.H., Kitamura N., Hashimoto T., Shirakawa O., Maeda K. Opposite changes in phosphoinositide-specific phospholipase C immunoreactivity in the left prefrontal and superior temporal cortex of patients with chronic schizophrenia. Biol. Psychiatry 1999, 46:1665-1671.
28. Lorrain D.S., Hull E.M. Nitric oxide increases dopamine and serotonin release in the medial preoptic area. NeuroReport 1993, 5:87-89.
29. Luth H.J., Holzer M., Gertz H.J., Arendt T. Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21ras and p16INK4a. Brain Res. 2000, 852:45-55.
30. Massmann G.A., Zhang J., Sallah J., Figueroa J.P. Developmental and regional expression patterns of Type I Nitric Oxide Synthase mRNA and protein in fetal sheep brain during the last third of gestation. Brain Res. Dev. Brain Res. 2000, 124:141-152.
31. Moskvina V., Craddock N., Holmans P., Nikolov I., Pahwa J.S., Green E., et al. Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol. Psychiatry 2009, 14:252-260.
32. Ohyu J., Takashima S. Developmental characteristics of neuronal nitric oxide synthase (nNOS) immunoreactive neurons in fetal to adolescent human brains. Brain Res. Dev. Brain Res. 1998, 110:193-202.
33. Okumura T., Okochi T., Kishi T., Ikeda M., Kitajima T., Yamanouchi Y., et al. No association between polymorphisms of neuronal oxide synthase 1 gene (NOS1) and schizophrenia in a Japanese population. Neuromolecular Med. 2009, 11:123-127.
34. Reif A., Herterich S., Strobel A., Ehlis A.C., Saur D., Jacob C.P., et al. A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol. Psychiatry 2006, 11:286-300.
35. Saur D., Seidler B., Paehge H., Schusdziarra V., Allescher H.D. Complex regulation of human neuronal nitric-oxide synthase exon 1c gene transcription. Essential role of Sp and ZNF family members of transcription factors. J. Biol. Chem. 2002, 277:25798-25814.
36. Saur D., Vanderwinden J.M., Seidler B., Schmid R.M., De Laet M.H., Allescher H.D. Single-nucleotide promoter polymorphism alters transcription of neuronal nitric oxide synthase exon 1c in infantile hypertrophic pyloric stenosis. Proc. Natl Acad. Sci. USA 2004, 101:1662-1667.
37. Shinkai T., Ohmori O., Hori H., Nakamura J. Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia. Mol. Psychiatry 2002, 7:560-563.
38. Tang W., Huang K., Tang R., Zhou G., Fang C., Zhang J., et al. Evidence for association between the 5' flank of the NOS1 gene and schizophrenia in the Chinese population. Int. J. Neuropsychopharmacol. 2008, 11:1063-1071.
39. Walsh T., McClellan J.M., McCarthy S.E., Addington A.M., Pierce S.B., Cooper G.M., et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008, 320:539-543.
40. Wass C., Klamer D., Fejgin K., Palsson E. The importance of nitric oxide in social dysfunction. Behav. Brain Res. 2009, 200:113-116.
41. Yao J.K., Leonard S., Reddy R.D. Increased nitric oxide radicals in postmortem brain from patients with schizophrenia. Schizophr. Bull. 2004, 30:923-934.